Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)

BACKGROUND: Management of metastatic melanoma is changing rapidly following the introduction of innovative effective therapies, with consequences for the allocation of healthcare resources. The objective of this study was to assess hospitalisation costs of metastatic melanoma in France from 2011 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Jérôme, Bregman, Bruno, Combemale, Patrick, Amaz, Camille, de Léotoing, Lucie, Vainchtock, Alexandre, Gaudin, Anne-Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549336/
https://www.ncbi.nlm.nih.gov/pubmed/28789648
http://dx.doi.org/10.1186/s12913-017-2472-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549336/
https://www.ncbi.nlm.nih.gov/pubmed/28789648
http://dx.doi.org/10.1186/s12913-017-2472-0

Ejemplares similares